Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia
Clinical trial NCT03571087 · COMPLETED
Trial details
- NCT number
- NCT03571087
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-08-01
- Enrollment
- 374
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.